Analysts at StockNews.com initiated coverage on shares of Maiden (NASDAQ:MHLD - Get Free Report) in a report released on Wednesday. The firm set a "sell" rating on the insurance provider's stock.
Maiden Stock Performance
NASDAQ:MHLD traded up $0.01 during trading hours on Wednesday, reaching $0.96. The company had a trading volume of 241,925 shares, compared to its average volume of 132,210. The firm's 50 day moving average price is $0.83 and its 200-day moving average price is $1.24. The firm has a market cap of $95.52 million, a price-to-earnings ratio of -1.48 and a beta of 1.60. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 1.22. Maiden has a 52 week low of $0.55 and a 52 week high of $2.27.
Maiden (NASDAQ:MHLD - Get Free Report) last posted its quarterly earnings data on Monday, March 10th. The insurance provider reported ($1.53) earnings per share (EPS) for the quarter. Maiden had a negative return on equity of 16.55% and a negative net margin of 71.58%. The business had revenue of ($6.64) million during the quarter.
Hedge Funds Weigh In On Maiden
Hedge funds have recently modified their holdings of the stock. SG Americas Securities LLC boosted its holdings in shares of Maiden by 58.5% during the 4th quarter. SG Americas Securities LLC now owns 46,096 shares of the insurance provider's stock valued at $78,000 after purchasing an additional 17,017 shares during the last quarter. State Street Corp lifted its position in shares of Maiden by 0.5% in the third quarter. State Street Corp now owns 1,201,024 shares of the insurance provider's stock worth $2,126,000 after buying an additional 6,341 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Maiden by 8.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 260,103 shares of the insurance provider's stock valued at $460,000 after buying an additional 19,664 shares during the last quarter. Barclays PLC grew its holdings in Maiden by 268.8% during the 3rd quarter. Barclays PLC now owns 115,740 shares of the insurance provider's stock valued at $205,000 after buying an additional 84,359 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in Maiden by 244.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 135,152 shares of the insurance provider's stock worth $239,000 after acquiring an additional 95,927 shares during the last quarter. Hedge funds and other institutional investors own 21.78% of the company's stock.
About Maiden
(
Get Free Report)
Maiden Holdings, Ltd., through its subsidiaries, provides property and casualty insurance and reinsurance solutions to regional and specialty insurers in Europe, North America, and internationally. It operates in two segments, Diversified Reinsurance and AmTrust Reinsurance. The company writes treaties on a quota share basis and excess of loss basis.
Further Reading
Before you consider Maiden, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maiden wasn't on the list.
While Maiden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
